Learn More
A prevalence study of epilepsy in patients with Down syndrome (n = 85) in three age-groups (14-16 years, 23-29 years, 50-60 years) was conducted in the county of Aarhus, Denmark. Seventy-two patients (85%) participated. An interview and a neurological examination were performed. An EEG was recorded in 50 patients. Twelve patients (17%) had epilepsy.(More)
s Abstracts presented at the Annual Scientific Meeting of the British Branch of the International League Against Epilepsy, 10 May 1996, Birmingham, UK 157 NUMBER 3 SEPTEMBER 1996 V Clinical Controversy New antiepileptic drug trials in developing countries: are they necessary? M.C. Walker, J.W.A.S. Sander Original articles Can human polyclonal immunoglobulin(More)
High-dose antioxidant supplementation has recently been recommended for multiple sclerosis (MS) patients. This study tests the clinical safety, the glutathione peroxidase (GSH-px) activity, and the absorption of selenium during such supplementation. Eighteen MS patients were given 6 tablets especially made for this study, equivalent to 6 mg sodium selenite,(More)
Glutathione peroxidase, one of the major antioxidants in the human brain, has been found to have decreased activity in patients suffering from multiple sclerosis (MS). This study compares the activity of lymphocyte glutathione peroxidase (L-GSH-px) in MS patients suffering from acute relapses with clinically stable MS patients and with control patients(More)
  • 1